The Babak Lab HK

We’re happy to share that Alisa Potapova, Pasha Ivanov Rostovtsev, and Anna Kirsanova recently attended the @CityU HK300 training, where they had the opportunity to further develop their project presentation skills. #LabLife #CityU #HK300

📸 Image generated using Sora by OpenAI. Article link: nature.com/articles/s4158…

Today we highlight a new @NaturePortfolio study revealing an unexpected mechanism tumors use to sustain growth. The study investigates how tumors acquire cysteine, a critical amino acid for survival, under nutrient-limited conditions. Link in the comments 👇

📸 Image generated using Sora by OpenAI. Article link: fda.gov/drugs/resource…

The @US_FDA has approved Lifyorli (relacorilant) in combination with chemotherapy for platinum-resistant ovarian cancer, a setting with limited treatment options. Link in the comments 👇 #Oncology #FDA #OvarianCancer #ClinicalTrials #CancerResearch

We would like to warmly congratulate Prof. Babak on receiving the CityUHK Teaching Excellence Award 2025/26! 🎉 Congratulations, Prof. Babak! We wish you continued success and further achievements!

📸 Image generated using Sora by OpenAI. Article link: nature.com/articles/s4158…

New in @NaturePortfolio: making therapy work in solid tumors, addressing one of the key challenges in oncology: poor efficacy of cell therapies in solid tumors. Link in the comments 👇 #CRISPR #CancerResearch #Immunotherapy #CellTherapy #SolidTumors #Oncology #Nature

📸 Image generated using Sora by OpenAI. Article link: fda.gov/drugs/resource…

The @US_FDA has approved nivolumab in combination with chemotherapy for previously untreated classical Hodgkin lymphoma, based on results from the SWOG S1826 trial. Link in the comments 👇

We gathered together to celebrate the birthdays of Kirill and Daniil! 🎉 A nice moment to gather together, eat splendid cakes and just talk about everything! ❤️ Wishing them both a fantastic year ahead filled with enthusiasm, strength, good health and new ideas 🥳 #LabLife

📸 Image generated using Sora by OpenAI. Article link: nature.com/articles/s4155…

A new study in @NaturePortfolio identifies a lipid modification pathway that regulates a key epigenetic enzyme in metastatic breast cancer. Link in the comments 👇 #CancerResearch #Epigenetics #Metastasis #BreastCancer #CellBiology #Acetylation #NatureCellBiology

📸 Image generated using Sora by OpenAI. Article link: nejm.org/doi/full/10.10…

NEJM phase 3 study reports that adding obinutuzumab to standard therapy significantly improves disease control in patients with active systemic lupus erythematosus (SLE). Link in the comments 👇 #Autoimmunity #Lupus #SLE #ClinicalTrials #Immunology #NEJM #Rheumatology

@NEJM phase 3 study reports that adding obinutuzumab to standard therapy significantly improves disease control in patients with active systemic lupus erythematosus (SLE). Link in the comments 👇 #Autoimmunity #Lupus #SLE #ClinicalTrials #Immunology #NEJM #Rheumatology

@NEJM phase 3 study reports that adding obinutuzumab to standard therapy significantly improves disease control in patients with active systemic lupus erythematosus (SLE). Link in the comments 👇 #Autoimmunity #Lupus #SLE #ClinicalTrials #Immunology #NEJM #Rheumatology

We would like to congratulate every woman with the recent international women’s day! 🌸 It was a great occasion to pause for a moment, spend time together, and celebrate the incredible women who contribute to science, research, and our community every day. 🤗🌷

📸 Image generated using Sora by OpenAI. Article link: pnas.org/doi/10.1073/pn…

New in PNAS: macrophage–tumor adhesion forces as a previously underappreciated physical mechanism supporting early tumor establishment. Targeting integrin-mediated interactions such as CD11c may represent a strategy to disrupt early tumor growth. Link in the comments 👇